1 / 19

Chapter 5: Renal Allograft Biopsy Wong Hin Seng

Chapter 5: Renal Allograft Biopsy Wong Hin Seng. Table 5.2.1: Number of renal allograft biopsy, 2004-2010. 4 th MRRB report 2010, Malaysia. Figure 5.2.1: Number of renal allograft biopsy, 2004-2010. Allograft biospy. 200. 180. 160. 140. 120. 100. Number of renal transplant biopsy. 80.

sabine
Download Presentation

Chapter 5: Renal Allograft Biopsy Wong Hin Seng

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chapter 5:Renal Allograft BiopsyWong Hin Seng

  2. Table 5.2.1: Number of renal allograft biopsy, 2004-2010 4th MRRB report 2010, Malaysia

  3. Figure 5.2.1: Number of renal allograft biopsy, 2004-2010 Allograft biospy 200 180 160 140 120 100 Number of renal transplant biopsy 80 60 40 20 0 2007 2009 2004 2005 2006 2008 2010 Year 4th MRRB report 2010, Malaysia

  4. Table 5.2.2: Number of renal allograft biopsy by centre, 2004-2010 4th MRRB report 2010, Malaysia

  5. Table 5.2.3: Renal allograft biopsy by year and age group, rate per million population, 2004-2010 4th MRRB report 2010, Malaysia

  6. Continue; 4th MRRB report 2010, Malaysia

  7. Figure 5.2.3: Renal allograft biopsy by year and age group, rate per million population, 2004-2010 >65 <15 15-<25 25-<35 35-<45 45-<55 55-<65 1.8 1.6 1.4 1.2 Rate (Per million population) 1 0.8 0.6 0.4 0.2 0 2004 2005 2006 2007 2008 2009 2010 Year 4th MRRB report 2010, Malaysia

  8. Table 5.3: Indications for renal allograft biopsy, 2004-2010 * Patients may have one or more clinical presentation * 48 patients have no information on clinical presentation (neither urine abnormalities nor graft function) For 2004, 1 patient has 2 indications For 2006, 4 patients have 2 indications For 2007, 5 patients have 2 indications For 2008, 6 patients have 2 indications For 2009, 11 patients have 2 indications For 2010, 7 patients have 2 indications 4th MRRB report 2010, Malaysia

  9. Table 5.4: Timing of renal allograft biopsy, 2004-2010 (dates: date of biopsy & date of transplant) 4th MRRB report 2010, Malaysia

  10. Figure 5.4: Timing of renal allograft biopsy, 2004-2010 Within 1 week >1 week to 1month > 1month to 3 months > 3 months to 6 months > 6months to 1 year >1 yr post transplant 90 80 70 60 50 NUmber of timing of graft biopsy 40 30 20 10 0 2004 2005 2006 2007 2008 2009 2010 Year 4th MRRB report 2010, Malaysia

  11. Table 5.5.1: Biopsy method, 2004-2011 *No data on biopsy technique 4th MRRB report 2010, Malaysia

  12. Figure 5.5.1: Biopsy method (censored for missing data), 2004-2010 Blind Not US guided US guided: Real time US guided: Not real-time 1.0 0.9 0.8 0.7 0.6 0.5 Propotion of biopsy method 0.4 0.3 0.2 0.1 0.0 2004 2005 2006 2007 2008 2009 2010 Year 4th MRRB report 2010, Malaysia

  13. Table 5.5.2: Number of passes, 2004-2011 4th MRRB report 2010, Malaysia

  14. Figure 5.5.2: Number of passes, 2004-2011 2 4 6 3 1 5 70 60 50 40 Percentage (%) 30 20 10 0 2004 2005 2006 2007 2008 2009 2010 Year 4th MRRB report 2010, Malaysia

  15. Table 5.5.3: Number of glomeruli obtained on biopsy, 2004-2010 * No data information on the number of glomeruli 4th MRRB report 2010, Malaysia

  16. Figure 5.5.3: Number of glomeruli obtained on biopsy, 2004-2010 0 1-9 10-19 >20 Missing/Unknown* 60 50 40 Percentage (%) 30 20 10 0 2004 2005 2006 2007 2008 2009 2010 Year 4th MRRB report 2010, Malaysia

  17. Table 5.5.4: Type of complications, 2004-2011 a Mild complication is defined as presence of gross hematuria, perirenal collection, hematoma, or AVM that do not require intervention b Severe complication is defined as presence of hypotension or complications requiring intervention. c No data information for complications 4th MRRB report 2010, Malaysia

  18. Figure 5.6: Histological diagnosis, 2004-2010 Acute rejection Borderline rejection Calcineurin inhibitor toxicity Chronic allograft nephropathy Acute tubular necrosis PTLD** De novo Recurrent GN Diabetic nephropathy Others 60 50 40 Percentage(%) 30 20 10 0 2004 2005 2006 2007 2008 2009 2010 Year 4th MRRB report 2010, Malaysia

  19. Table 5.6 Histological diagnosis, 2004-2010 * Patients may have more than 1 diagnosis classification **Post Transplant Lymphoproliferative disease 4th MRRB report 2010, Malaysia

More Related